ARCHIVES

Phase II Elotuzumab Study Demonstrates 33 Months PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

ASCO Sees Efforts Pay Off In Health Care Reform: Clinical Trials

October 1, 1993

Come Out of Labs and Join Picket Pines, Congressman Urges

March 30, 1990

NIH Awards 24 More Grants For Women’s Health Initiative

October 14, 1994

Henderson, Weinstein, Jukes to Present AACR Award Lectures

March 6, 1987

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

NCI Clinical Trials Enrollment Drops to 17,500

February 21, 2014